The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index; 18 of the 33 sources its claims cite were checked for support.
Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling
Open accessAbstract
The study provides structural and mechanistic evidence that inactive α5β1-integrin can act as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling.
Overview
CoChat Summary
TL;DR
The paper provides structural and functional evidence that ANGPT2 binds simultaneously through its asymmetric FLDs to TIE2 and α5β1-integrin, with inactive β1-integrin at endothelial junctions acting as a scaffold for ANGPT/TIE2/FOXO1 signaling. It proposes that inactive α5β1-integrin promotes junctional TIE2 accumulation and FOXO1 nuclear exclusion, whereas ANGPT2 can engage active β1-integrin via its SCD when TIE2 is absent.
Key findings
- ANGPT2 engages α5β1-integrin through both N- and C-terminal domains: the FLD binds α5Calf1 (Kd 50–90 nM for α5Calf1-2; MST WT α5Calf1 4 nM, mutants undetectable), while the SCD binds the β1-integrin PSI domain (Kd 2–5 nM for β1-ECD; ANGPT2 19–76 Kd 80 nM, ANGPT2 19–202 Kd 10 nM).
- The α5Calf1-2 crystal structure was solved alone at 1.92 Å and in complex with an ANGPT2 peptide (E358–Q366); MD simulations and mutagenesis validated the interface, and SEC-SAXS supported a 2:1 ANGPT2–α5Calf1-2 complex and a trimeric ANGPT2–α5Calf1-2–TIE2 LBD complex (measured 165.6 kDa vs theoretical 177.5 kDa; favored model χ² = 1.9).
- Inactive β1-integrin colocalized with ANGPT-induced TIE2 at EC-EC junctions; PLA detected TIE2 with inactive β1-integrin (mAb13) but not active β1-integrin (9EG7), and stabilizing inactive β1-integrin with AIIB2 increased junctional TIE2 and decreased nuclear FOXO1 in an ANGPT2- and TIE2-dependent manner.
- In vivo, endothelial β1-integrin deletion in adult mice reduced venous total and pY992-TIE2, and LPS endotoxemia reduced junctional β1-integrin along with pY992-TIE2; oligomeric ANGPT2 (141 kDa dimer, 383 kDa oligomer) activated TIE2/AKT and decreased nuclear FOXO1, blocked by BAY-826 or LY294002.
Methods
- Cell-based assays used HUVECs, human dermal BECs, LECs, CHO, HEK293FT, and insect cells; mouse experiments used endothelial-specific Itgb1 deletion in adult mice and LPS-induced endotoxemia, with both male and female mice examined.
- Structural and biophysical approaches included SPR, MST, SEC-MALS, X-ray crystallography, SEC-SAXS, atomistic MD simulations (n = 3 repeats of 1 μs each), mutagenesis, proximity ligation assay, bulk RNA-Seq, VIPER, and GSEA.
- Statistics used GraphPad Prism 9 with 2-tailed unpaired t tests or 1-way/2-way ANOVA followed by Tukey’s post hoc testing; P < 0.05 was considered significant, and data are presented as mean ± SEM or as indicated.
Limitations
- Stated by the paper: the study primarily focuses on cell-based assays and protein–protein interactions and does not comprehensively capture all in vivo contexts of β1-integrin function in ANGPT/TIE signaling; ANGPT2 signaling modes may overlap depending on relative bioavailability and ANGPT1 occupancy of TIE2; ANGPT2 oligomerization was not assessed in vivo; α5β1-integrin was used as a tractable model because α9 integrin structure remains unresolved.
- Evident from the text: in vivo quantitative analysis of junctional β1-integrin in the lymphatic vasculature was limited because β1-integrin expression was low along dermal capillaries and enriched at lymphatic valves.
- Evident from the text: the full inactive α5β1-integrin–ANGPT2–TIE2 ternary model is based on SAXS, MD, mutagenesis, and previously published structures rather than a co-crystal structure of the complete ternary complex.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Regulation of phosphorylated TIE2 and β1-integrin in cell junctions in Itgb1iECKO mice and in endotoxemia. (A and B) Vena cava from Itgb1iECKO and control (Ctrl) mice were stained for β1-integrin (HMb1), pY992-TIE2 (pTIE2), and VE-cadherin (CDH5). Larger fields of view are shown in Supplemental Figure 3A. (C and D) Quantification of junctional HMb1 (C) and junctional pTIE2 (D) normalized to CDH5. n = 3 mice per group. (E) Correlation of junctional pTIE2 with HMb1 in Ctrl and Itgb1iECKO mice per image. There was a positive correlation between pTIE2 and HMb1 (Pearson’s r = 0.590 [95% CI 0.303–0.778]; n = 32 images; 2-tailed P = 0.0004). (F and G) Vena cava from control mice and after LPS administration for 16 hours were stained for inactive β1-integrin (HMb1), pTIE2, and CDH5. Larger fields of view are shown in Supplemental Figure 3E. (H and I) Quantification of junctional HMb1 (H) and junctional pTIE2 (I) normalized to CDH5. n = 4 mice per group. (J) Correlation of junctional pTIE2 vs. HMb1. There was a strong positive correlation between pTIE2 and HMb1 (Pearson’s r = 0.877 [95% CI 0.763–0.938]; n = 33; 2-tailed P < 0.0001). (K and L) Western blot for phosphotyrosine and TIE2 after TIE2 immunoprecipitation from lung lysates from control and Itgb1iECKO mice and from control mice after LPS administration for 16 hours (K). Quantification of phosphorylated TIE2/total TIE2, normalized to control (Ctrl) (L). n = 9, 10 (Itgb1iECKO), and 4 (LPS) mice per group. Scale bars: 20 μm (B and G). Confocal Z-stack projections are shown. Statistical tests were as follows: 2-tailed t test (C, D, H, and I); 1-way ANOVA with Tukey’s post hoc test (L); and Pearson’s correlation (E and J). Data are presented as mean ± SD (C, D, H, and I)and ± SEM (L). *P < 0.05, **P < 0.01, ***P < 0.001. Tamoxifen, TAM.](https://figures.cochat.ai/paper-figures/aa7e5ffd9aff49f0baa0b396f869a33e/inactive-1-integrin-acts-as-a-junctional-scaffold-for-angiopoietin-tie2-foxo1-figure-2.jpg)

![Figure 4 Inactive β1-integrin facilitates ANGPT2/TIE2/FOXO1 signaling in LECs. (A) Schematic representation of ANGPT2/TIE2/FOXO1 pathway and AIIB2 antibody recognizing non–ECM-bound β1-integrin. (B and C) LECs stimulated with control or AIIB2 antibody for 60 minutes were stained for surface TIE2, CDH5, and AIIB2 (using secondary antibodies) (C). Quantification of junctional TIE2 normalized to number of nuclei (B). (D and E) LECs were stimulated with AIIB2 antibody for 30 and 60 minutes and stained for FOXO1 and AIIB2 (see Supplemental Figure 6A for staining at 60 minutes) (D). Quantification of nuclear/cytoplasmic FOXO1 ratio normalized to nuclei (E). (F and G) LECs were stimulated with ANGPT2 (A2) oligomer, rhAng2, or AIIB2 antibody and FOXO1 were analyzed using immunoblotting from nuclear and cytoplasmic fractions, using lamin A/C and α-tubulin markers, respectively. (H and I) shANGPT2- and shScr-treated LECs were stimulated with AIIB2 antibody for 60 minutes and stained for FOXO1, TIE2, and AIIB2. Nuclear/cytoplasmic FOXO1 ratio was quantified normalized to nuclei. n = 3 (B, E, G [n = 5 for control, n = 4 for A2 oligomer], and H) or n = 5 (E) independent experiments. Statistical tests included 2-tailed t test (B) and 1-way ANOVA with Tukey’s post hoc test (E, G, and H). Data are presented as mean ± SEM. Scale bars: 50 μm (C), 25 μm (D and I). Confocal Z-stack projections are shown. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.](https://figures.cochat.ai/paper-figures/e35e654fb28f4b419b60a972c56fc48c/inactive-1-integrin-acts-as-a-junctional-scaffold-for-angiopoietin-tie2-foxo1-figure-4.jpg)

![Figure 6 Crystal structure and MD simulations reveal the interface of ANGPT2 FLD–α5Calf1-2 complex. (A) Crystal structure of apo α5Calf1-2. (B) Crystal structure of α5Calf1-2 in complex with the ANGPT2 peptide (blue) [residue E358–Q366, P(1)–P(9)]. (C) Schematic representation of ANGPT2 peptide (blue) bound to α5Calf1. (D) Electron density of the ANGPT2 peptide bound to α5Calf1-2 visible in the co-crystal structure in (B). The peptide is seen interacting with several residues in Calf1; see text for details. (E and F) Binding of WT (E) and mutant α5Calf1 (Arg694Trp, Asn724Val, Gln766Glu) (F, no binding is detected) to fluorescently labelled ANGPT2-FLD-Fc in MST. (G) An optimized docked model of an ANGPT2-FLD dimer in complex with α5Calf1-2. Residue E358–Q366, corresponding to the ANGPT2 peptide used in the crystal structure in (B), is indicated in bright blue. (H and I) Atom-scale MD simulation of ANGPT2-FLD dimer in complex with α5Calf12 (n = 3). Thickness of the line indicates frequency of interaction (H). Heatmap of interaction frequencies of amino acid residues of α5Calf1-2 (x axis) and ANGPT2-FLD dimer (y axis) from MD simulation (I). (J and K) Binding of mutant α5Calf1 (Arg755Glu, Gln762Ala, Asp764Asn (J) and Arg694Trp, Arg755Glu, Gln762Ala, Gln766Glu) (K) to fluorescently labelled ANGPT2-FLD-Fc in MST. No binding is detected in (K), and binding is decreased to a micromolar scale in (J) as compared with wt in (E). (L) Substituted amino acid residues shown in a close-up of the docked model in G. n = 3 independent experiments (E, F, J, and K).](https://figures.cochat.ai/paper-figures/0add70eb9aef4645abf74832b9c677d4/inactive-1-integrin-acts-as-a-junctional-scaffold-for-angiopoietin-tie2-foxo1-figure-6.jpg)


Verification
Claims the paper makes
13 Valid · 0 Not valid · 7 Not checked · 119 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“whereas inferred activity of MYC, a FOXO1-repressed target (45) as well as the E2F1 transcription factor, were increased”
§ Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling > Results > Oligomeric ANGPT2 activates TIE2/FOXO1 signaling facilitated by inactive β1-integrin.
What the sources say
- Supportedcites [45] source
Citation (45) is attached to the description of MYC as FOXO1-repressed, not to the citing authors’ VIPER result. The paper reports that FOXO1 overexpression suppressed MYC expression in endothelial cells, while FOXO1 depletion increased it (text discussing Fig. 3j–l; page unavailable in our copy). (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“DEGs induced by oligomeric ANGPT2 overlapped with genes downregulated by constitutively active FOXO1 in HUVECs (42) (P < 0.00001)”
§ Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling > Results > Oligomeric ANGPT2 activates TIE2/FOXO1 signaling facilitated by inactive β1-integrin.
What the sources say
- Partly supportedcites [42] sourceExperimental — accuracy not yet measured
The Results section ('Prevalent FOXO1-regulated transcription in Pik3caH1047R BECs'; page unavailable) reports overlap between genes upregulated in Pik3ca-mutant endothelial cells and genes suppressed by constitutively active FOXO1A3 in HUVECs. It does not identify the overlapping DEGs as induced by oligomeric ANGPT2. The P < 0.00001 in the Fig. 5 caption is a threshold for identifying DEGs, not a reported significance test of that overlap. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Oligomeric ANGPT2 also induced a proliferative transcriptional signature in LECs, consistent with the established role of FOXO1 in suppressing EC proliferation (45).”
§ Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling > Discussion
What the sources say
- Supportedcites [45] source
The citation supports the sentence’s background point about FOXO1, not the citing authors’ finding about oligomeric ANGPT2 in LECs. The paper states in its main text (indexed under Abstract; page unavailable) that FOXO1 suppresses endothelial growth and proliferation, and Extended Data Figure 3 reports reduced endothelial proliferation when FOXO1 is overexpressed. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Because we previously found that the ANGPT2 N-terminus, but not that of ANGPT1, activated α5β1-integrin (22), and here we further show that the ANGPT1 N-terminus does not bind β1-integrin, these data suggest ANGPT2 may facilitate α5β1-integrin activation by interacting with the hybrid/PSI domain in a unique manner not mediated by ANGPT1.”
§ Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling > Discussion
What the sources say
- Supportedcites [22] source
The citation attaches to the statement about the prior finding, not the citing authors’ new hybrid/PSI-domain proposal. In Results and Discussion (‘Ang2, but not Ang1, activates β1-integrin’), the source reports that the Ang2 N-terminal domain promoted β1-integrin activation while the Ang1 N-terminal domain did not; its activation assay measured α5β1-integrin activity. (LLM, conf=0.92)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Analysis of the full-length β1-ECD using SAXS, both alone and in complex with ANGPT219–76–SUMO, indicated an elongated shape (DAMMIF reconstruction; ref. 52) consistent with the extended integrin conformation”
§ Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling > Results > ANGPT2 SCD binds extended β1-integrin.
What the sources say
- Supportedcites [52] source
The citation is attached to “DAMMIF reconstruction,” identifying the method used, rather than attributing the β1-ECD finding to this source. The Introduction describes DAMMIF as an ab-initio method for reconstructing particle shape from small-angle scattering data. (LLM, conf=0.92)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
96 more claims · 3 with their cited sources checked
Create a free account to see all 139 claims and to verify the 4 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 30
- The quote only partly states this claim. 1
Citations
Cites
Direct observation of individual endogenous protein complexes in situ by proximity ligation
Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K.-J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L.-G., et al. (2006) · Nature Methods · doi:10.1038/nmeth947 · Cited by 2,419 · cited 4×
“…Because ANGPT2 is known to activate β 1 -integrin (21, 22), we further assessed the compartmentalization of ANGPT2 and TIE2 with the active and inactive β 1 -integrin conformers in ECs, using a proximity ligation assay (PLA) (36), which can detect proteins less than 40 nm from each other.”
InfluentialDAMMIF , a program for rapid ab-initio shape determination in small-angle scattering
Franke, D., & Svergun, D. I. (2009) · Journal of Applied Crystallography · doi:10.1107/s0021889809000338 · Cited by 2,021
The HDOCK server for integrated protein–protein docking
Yan, Y., Tao, H., He, J., & Huang, S.-Y. (2020) · Nature Protocols · doi:10.1038/s41596-020-0312-x · Cited by 1,857 · cited 1×
“50) and refined it against experimental SAXS data for ANGPT2 19–76 –SUMO using rigid body modelling (SASREF) (51), showing a good fit ( χ ² = 1.85) (Supplemental Figure 12, A and B).”
InfluentialIntegrins as biomechanical sensors of the microenvironment
Kechagia, J. Z., Ivaska, J., & Roca-Cusachs, P. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0134-2 · Cited by 1,311 · cited 2×
“This conformational activation correlates with increased binding of intracellular activators and extracellular matrix (ECM) proteins (27).”
Self-citationGale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00217-4 · Cited by 1,018 · cited 2×
“In LECs, ANGPT2 is secreted in an autocrine manner and acts as a TIE2 agonist, highlighting the context-dependent function of ANGPT2 signaling across vascular beds (11, 19, 20).”
Cell Spreading and Focal Adhesion Dynamics Are Regulated by Spacing of Integrin Ligands
Cavalcanti-Adam, E. A., Volberg, T., Micoulet, A., Kessler, H., Geiger, B., & Spatz, J. P. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.089730 · Cited by 922 · cited 1×
“Because ECM ligand spacing is known to regulate cell adhesion, ANGPT2 might act as a molecular ruler to spatially organize integrin heterodimers in cell adhesions (58).”
Global Rigid Body Modeling of Macromolecular Complexes against Small-Angle Scattering Data
Petoukhov, M. V., & Svergun, D. I. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.064154 · Cited by 899 · cited 4×
“SASREF modelling revealed a configuration consistent with SCD binding to the β 1 -integrin PSI domain ( χ ² = 1.86) (Figure 7, B–”
InfluentialVascular heterogeneity and specialization in development and disease
Potente, M., & Mäkinen, T. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.36 · Cited by 653
Self-citationTherapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620 · cited 2×
“ANGPT growth factors (ANGPT1 and ANGPT2) regulate both lymphatic and blood vascular development (7).”
Self-citationFOXO1 couples metabolic activity and growth state in the vascular endothelium
Wilhelm, K., Happel, K., Eelen, G., Schoors, S., Oellerich, M. F., Lim, R., Zimmermann, B., Aspalter, I. M., Franco, C. A., Boettger, T., et al. (2016) · Nature · doi:10.1038/nature16498 · Cited by 579 · cited 1×
“Oligomeric ANGPT2 also induced a proliferative transcriptional signature in LECs, consistent with the established role of FOXO1 in suppressing EC proliferation (45).”
Self-citation
Metadata
- Authors
- Sipilä, T., Ponna, S. K., Venkatesha Murthy, A., Pink, A., Enkavi, G., Bohra, S. K., Lewna, K., Ganesh, K., Liu, Q., Korhonen, M., Kajander, T., Potente, M., Ivaska, J., Vattulainen, I., Leppänen, V.-M., & Saharinen, P.
- Affiliations
- Translational Cancer Medicine Program, Research Programs Unit,
- Department of Physics, and
- University of Helsinki (FI)
- Max Delbrück Center (DE)
- Åbo Akademi University (FI)
- Corresponding author
- Saharinen, Pipsa
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2026-06-15
- Volume
- 136
- Issue
- 12
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC13262729
- OpenAlex
- W7164738136
- Semantic Scholar
- 7b7a9b03bd37ceda21cc225d2b9a35e11f22d057
- Cited by
- 0
- References
- 64
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- UTUPub (University of Turku) (submittedVersion)
- Funders
- European Research Council (773076)
- Research Council Finland (346134, 310075,347771,331349,336234)
- Human Frontier Science (RGP0059/2019)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- beta1 integrin, alpha5beta1 integrin, angiopoietin-2, Tie2, FOXO1, endothelial cells, cell-cell contact, receptor cross-talk, fibrinogen-like domain, nuclear exclusion, endotoxemia
- MeSH terms
- Forkhead Box Protein O1, Animals, Humans, Intercellular Junctions, Signal Transduction, Mice, Knockout, Integrin beta1, Integrin alpha5beta1, Angiopoietin-2, Receptor, TIE-2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling. https://app.cochat.ai/papers/10.1172/jci190552
- The paper
- Sipilä, T., Ponna, S. K., Venkatesha Murthy, A., Pink, A., Enkavi, G., Bohra, S. K., Lewna, K., Ganesh, K., Liu, Q., Korhonen, M., Kajander, T., Potente, M., Ivaska, J., Vattulainen, I., Leppänen, V.-M., & Saharinen, P. (2026). Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling. Journal of Clinical Investigation. https://doi.org/10.1172/jci190552
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.